A 55-year-old man with chronic obstructive pulmonary disease reports having some mild chest pain.
Hospitals may be missing opportunities to start tobacco use treatment immediately after myocardial infarction.
An overview of cardiac rehabilitation use plus interviews with Monica Mukherjee, MD, MPH, FACC, FASE and with Jonathan Ledyard, MS, RCEP.
The HEART Score is a safe risk-stratification tool for chest pain, but it does not seem to do much for reducing hospital utilization and admissions.
Evidence is lacking to support oxygen therapy for acute myocardial infarction.
Among patients with heterozygous familial hypercholesterolemia, alirocumab was associated with a 75% reduction in lipoprotein apheresis compared with placebo.
Experts say bioresorbable stents are "a few generations away" from being standard of care in interventional cardiology.
A composite end point of death, heart failure, new myocardial infarction, and revascularization was similar between the deferred stenting group and the conventional treatment group.
Poor adherence to dual antiplatelet therapy plays a significant role in outcomes for patients with acute coronary syndromes.
The American Association of Clinical Endocrinologists site lack of evidence of cardiovascular disease risk in testosterone therapy use.
Patients with confirmed or suspected acute myocardial infarction do not benefit from supplemental oxygen therapy.
Major adverse cardiovascular events were not reduced in patients with acute coronary syndrome undergoing planned percutaneous coronary intervention when given 2 loading doses of atorvastatin.
Women are less likely than men to fill a high-intensity statin prescription following hospitalization for myocardial infarction.
Although varenicline was effective for short-term smoking cessation, more than half of the patients in the EVITA trial relapsed after 1 year.
Two analyses were conducted, one during the training phase and the second during the validation phase of the study.
Time from first medical contact to primary percutaneous coronary intervention is inversely linked to short-term survival in STEMI.
In patients with diabetes who had an acute myocardial infarction, the acute-to-chronic glycemic ratio was a better predictor of mortality compared with baseline glycemia levels.
One lot of clopidogrel, a platelet inhibitor, has been recalled due to mislabeling.
Patients with multivessel coronary artery disease and diabetes may benefit more from coronary artery bypass grafting surgery vs percutaneous coronary intervention.
The American College of Cardiology and the American Heart Association have released updated quality and performance measures for STEMI and NSTEMI management.
The Cardiology Advisor Articles
- The Mounting Evidence Against Electronic Cigarette Use
- Entresto Significantly Improves Physical, Social Activity in Heart Failure Patients
- Oxygen Therapy in Acute MI Not Associated With Clinical Benefit
- Nonpsychotic Cannabinoids in Hypertension: Benefits and Harms
- ACC and AHA Release 2018 Quality Measures for Cardiac Rehabilitation